생세포 이미징 시장 : 제품 및 서비스, 기술, 용도, 최종 사용자별 - 세계 예측(2025-2030년)

The Live Cell Imaging Market was valued at USD 2.80 billion in 2023, expected to reach USD 3.08 billion in 2024, and is projected to grow at a CAGR of 10.37%, to USD 5.60 billion by 2030.

Live cell imaging, a pivotal tool in cell biology, allows researchers to observe living cells over time using advanced imaging techniques. Its scope encompasses diverse applications in drug discovery, cancer research, and stem cell biology, providing insights into cellular processes such as migration, differentiation, and proliferation. The necessity of live cell imaging lies in its ability to offer dynamic analysis at cellular and subcellular levels, which is crucial for understanding disease mechanisms and developing therapeutic strategies. The end-use scope stretches across research laboratories, hospitals, pharmaceutical companies, and academic institutions, underscoring its interdisciplinary demand.

Market insights reveal that technological advancements, including artificial intelligence and machine learning integration, are key growth factors, enabling enhanced image analysis and data management. The rise in chronic diseases and the demand for personalized medicine are also driving market expansion. Geographically, North America holds a dominant position due to robust research infrastructure, while Asia-Pacific shows significant potential for growth due to increased R&D investments and government initiatives.

However, high costs associated with sophisticated imaging systems and a lack of skilled professionals pose limitations to market growth. There are also challenges regarding data handling, storage, and standardization, which can hinder widespread adoption. To capitalize on emerging opportunities, companies should focus on developing cost-effective, user-friendly imaging systems and invest in training programs to build skilled user bases.

The best areas for innovation include the development of novel fluorescent probes, improvement in imaging resolution and efficiency, and real-time cellular analysis using automated platforms. Incorporating cloud-based solutions for data storage and sharing could also enhance collaborative research efforts. The live cell imaging market is highly dynamic, characterized by rapid technological advancements and intense competition, which necessitates continuous innovation and strategic collaborations to maintain and expand market presence.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Live Cell Imaging Market

The Live Cell Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing demand in clinical research for cellular development
  • Rising demand in cancer and nerves related treatment
  • Growing government investments in life sciences sector
• Market Restraints
  • High cost associated with live cell imaging
• Market Opportunities
  • Ongoing research and development in live cell imaging
  • Uses of advanced robotics and technology in live cell imaging
• Market Challenges
  • Complexity associated with the uses of live cell imaging

Porter's Five Forces: A Strategic Tool for Navigating the Live Cell Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Live Cell Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Live Cell Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Live Cell Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Live Cell Imaging Market

A detailed market share analysis in the Live Cell Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Live Cell Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Live Cell Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Live Cell Imaging Market

A strategic analysis of the Live Cell Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Live Cell Imaging Market, highlighting leading vendors and their innovative profiles. These include Aligned Genetics, Axion BioSystems, Inc., Becton, Dickinson and Company, BestScope International Limited, Bruker Corporation, Carl Zeiss AG, Curiosis Inc., CYTENA GmbH by Bico Group AB, Cytoskeleton, Inc., CytoSMART Technologies BV, Danaher Corporation, Fluxion Biosciences Inc., Keyence Corporation, Merck KGaA, Molecular Devices, LLC, NanoEntek America, Inc., Nanolive SA, Nikon Corporation, Olympus Corporation, Oxford Instruments PLC, Panasonic Corporation, PerkinElmer Inc., Phase Focus Limited, Proteintech Group, Inc., Sartorius AG, Teledyne Technologies Incorporated, Thermo Fisher Scientific Inc., Vieworks Co., Ltd., and Yokogawa Electric Corporation.

Market Segmentation & Coverage

This research report categorizes the Live Cell Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Consumables, Instruments, Services, and Software. The Consumables is further studied across Assay Kits, Media, and Reagents. The Instruments is further studied across Accessories, Cell Analyzers, Microscopes, and Standalone Systems.
• Based on Technology, market is studied across Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, High-content screening, and Time-lapse Microscopy.
• Based on Application, market is studied across Cell Biology, Developmental Biology, Drug Discovery, and Stem Cells.
• Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations (CROs), and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand in clinical research for cellular development
    • 5.1.1.2. Rising demand in cancer and nerves related treatment
    • 5.1.1.3. Growing government investments in life sciences sector
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with live cell imaging
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development in live cell imaging
    • 5.1.3.2. Uses of advanced robotics and technology in live cell imaging
  • 5.1.4. Challenges
    • 5.1.4.1. Complexity associated with the uses of live cell imaging
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Live Cell Imaging Market, by Product & Service

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Assay Kits
  • 6.2.2. Media
  • 6.2.3. Reagents
• 6.3. Instruments
  • 6.3.1. Accessories
  • 6.3.2. Cell Analyzers
  • 6.3.3. Microscopes
  • 6.3.4. Standalone Systems
• 6.4. Services
• 6.5. Software

7. Live Cell Imaging Market, by Technology

• 7.1. Introduction
• 7.2. Fluorescence Recovery After Photobleaching
• 7.3. Fluorescence Resonance Energy Transfer
• 7.4. High-content screening
• 7.5. Time-lapse Microscopy

8. Live Cell Imaging Market, by Application

• 8.1. Introduction
• 8.2. Cell Biology
• 8.3. Developmental Biology
• 8.4. Drug Discovery
• 8.5. Stem Cells

9. Live Cell Imaging Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Contract Research Organizations (CROs)
• 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Live Cell Imaging Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Live Cell Imaging Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Live Cell Imaging Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aligned Genetics
• 2. Axion BioSystems, Inc.
• 3. Becton, Dickinson and Company
• 4. BestScope International Limited
• 5. Bruker Corporation
• 6. Carl Zeiss AG
• 7. Curiosis Inc.
• 8. CYTENA GmbH by Bico Group AB
• 9. Cytoskeleton, Inc.
• 10. CytoSMART Technologies BV
• 11. Danaher Corporation
• 12. Fluxion Biosciences Inc.
• 13. Keyence Corporation
• 14. Merck KGaA
• 15. Molecular Devices, LLC
• 16. NanoEntek America, Inc.
• 17. Nanolive SA
• 18. Nikon Corporation
• 19. Olympus Corporation
• 20. Oxford Instruments PLC
• 21. Panasonic Corporation
• 22. PerkinElmer Inc.
• 23. Phase Focus Limited
• 24. Proteintech Group, Inc.
• 25. Sartorius AG
• 26. Teledyne Technologies Incorporated
• 27. Thermo Fisher Scientific Inc.
• 28. Vieworks Co., Ltd.
• 29. Yokogawa Electric Corporation